comprehensive -WSS

comprehensive

author：fashion 2025-09-30 00:45:45 - browse：49

LONDON — AstraZeneca said Friday an experimental drug tamped down the progression of a certain type of breast cancer in a Phase 3 trial, a win for the company after the same drug produced underwhelming results in a lung cancer trial over the summer.

The drug, called datopotamab deruxtecan or Dato-DXd for short, succeeded on one of its primary endpoints of improving progression-free survival compared to chemotherapy in certain breast cancer patients who had previously been treated with other therapies.

AstraZeneca, which is developing Dato-DXd with partner Daiichi Sankyo, said that the data for the other primary endpoint of overall survival were not “mature” as of this interim analysis, but that there was a positive trend. The trial is continuing.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： 23andMe had bad news about my health. I wish a person had delivered it
Next article： Update the Apgar Score to remove skin color

hotspot

WSS

Readout Newsletter: Parkinson's study, Gilead, CG Oncology

The inclusion problem at the heart of rehabilitation research

New documents shed light on MD Anderson Cancer Institute feud

Immunocompromised patients offer clues on chronic Covid

Medicare bonuses could stop drug shortages under Senate plan

Community Health Systems hospitals under DOJ investigation

explore

comprehensive

focus

Virginia high school admissions case could be legal follow

To bolster infectious disease surveillance, genomics powerhouses team up

Medical records are filled with copy

Neurocrine Biosciences, biotech based in San Diego, joins PhRMA

Activists slam private health insurers over coverage restrictions

Update the Apgar Score to remove skin color

The cancer drug shortage isn’t new — and neither are the solutions

Head of FDA's diagnostics center, who led through Covid, retires

At least 13 dead in Texas as scorching temps continue

FDA sets aggressive timeline for overhauling inspection procedures

entertainment

Alabama frozen embryo ruling has major implications for IVF clinics

Pumping milk in bathrooms at health conferences is common

With competition flaring, obesity drug hits goal in liver disease study

Dario to buy mental health app maker Twill in cash and stock deal

With competition flaring, obesity drug hits goal in liver disease study

HPV vaccine, cervical cancer study delivers historic results

focus

hotspot

entertainment

focus